Australia's most trusted
source of pharma news
Sunday, 03 May 2026
Posted 1 May 2026
Four new faces have joined the Medicines Australia Board with Lilly's Manny Simons, GSK's Andrew Thomas, MSD's Chifumi Umeda and UCB's Selena Clifford named as Directors.
Voting closed on Wednesday in what emerged as a fierce competition, with 10 Country Leaders putting their hand up for just four available Board positions with the industry's peak organisation.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.